TickerFacts.

A business in context

PRME research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-20 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001628280-26-053883

  2. 8-K · Current report

    Report date 2026-08-06 · 0001628280-26-053878 · Items 2.02,9.01

  3. 8-K · Current report

    Report date 2026-07-06 · 0001628280-26-047590 · Items 8.01

  4. 4 · Ownership change

    Report date 2026-06-05 · 0001628280-26-041579

  5. 4 · Ownership change

    Report date 2026-06-05 · 0001628280-26-041575

  6. 4 · Ownership change

    Report date 2026-06-05 · 0001628280-26-041572

  7. 4 · Ownership change

    Report date 2026-06-05 · 0001628280-26-041569

  8. 4 · Ownership change

    Report date 2026-06-05 · 0001628280-26-041566

  9. 4 · Ownership change

    Report date 2026-06-05 · 0001628280-26-041560

  10. 4 · Ownership change

    Report date 2026-06-05 · 0001628280-26-041553

  11. 8-K · Current report

    Report date 2026-06-05 · 0001628280-26-041543 · Items 5.07

  12. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001628280-26-031726

  13. 8-K · Current report

    Report date 2026-05-07 · 0001628280-26-031719 · Items 2.02,9.01

  14. DEF 14A · Proxy statement

    Report date 2025-12-31 · 0001628280-26-026697

  15. 4 · Ownership change

    Report date 2026-04-16 · 0001470831-26-000388

  16. 8-K · Current report

    Report date 2026-04-07 · 0001628280-26-025372 · Items 5.02

  17. 10-K · Annual report

    Report date 2025-12-31 · 0001628280-26-013569

  18. 8-K · Current report

    Report date 2026-03-03 · 0001628280-26-013565 · Items 2.02,7.01,9.01

  19. 8-K · Current report

    Report date 2026-01-12 · 0001628280-26-001773 · Items 7.01,9.01

  20. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001628280-25-050422

  21. 8-K · Current report

    Report date 2025-11-07 · 0001628280-25-050415 · Items 2.02,9.01

  22. 8-K · Current report

    Report date 2025-09-08 · 0001894562-25-000056 · Items 7.01,9.01

  23. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001628280-25-038619

  24. 8-K · Current report

    Report date 2025-08-07 · 0001628280-25-038617 · Items 2.02,9.01

  25. 8-K · Current report

    Report date 2025-08-01 · 0001628280-25-037840 · Items 5.02,5.07

  26. 8-K · Current report

    Report date 2025-07-30 · 0001628280-25-037076 · Items 1.01,9.01

  27. 8-K · Current report

    Report date 2025-07-30 · 0001628280-25-036705 · Items 2.02,8.01,9.01

  28. 8-K · Current report

    Report date 2025-07-14 · 0001628280-25-034971 · Items 5.02

  29. DEF 14A · Proxy statement

    Report date 2025-08-01 · 0001193125-25-158716

  30. 8-K · Current report

    Report date 2025-06-04 · 0001628280-25-029646 · Items 5.07,9.01

  31. 8-K · Current report

    Report date 2025-05-16 · 0001193125-25-122156 · Items 5.02,7.01,8.01,9.01

  32. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001628280-25-023486

  33. 8-K · Current report

    Report date 2025-05-08 · 0001628280-25-023482 · Items 2.02,9.01

  34. DEF 14A · Proxy statement

    Report date 2024-12-31 · 0001628280-25-018704

  35. 8-K · Current report

    Report date 2025-03-18 · 0001193125-25-056122 · Items 7.01,8.01,9.01

  36. 10-K · Annual report

    Report date 2024-12-31 · 0001628280-25-008884

  37. 8-K · Current report

    Report date 2025-02-28 · 0001628280-25-008873 · Items 2.02,9.01

  38. 8-K · Current report

    Report date 2025-01-13 · 0001628280-25-001244 · Items 7.01,9.01

  39. SC 13D/A · Ownership disclosure

    0001072613-24-000898

  40. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001628280-24-047130

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

0 matching transaction rows.

No matching transaction rows in the covered quarter. This does not establish that no insider transactions occurred.

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001894562Prime Medicine, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    Year endedReported USD revenueCPI-adjusted USD revenue
    2024-12-31$2.98M$3.20M
    2023-12-31$0$0
    2022-12-31$0$0
    2021-12-31$0$0
    2020-12-31$5.21M$6.78M

    Bureau of Labor Statistics · retrieved 2026-10-20 · 9 selected series; gaps remain missing

    Explore the CPI history ↗